Immunology Letters

Papers
(The H4-Index of Immunology Letters is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Lymphopenia during the COVID-19 infection: What it shows and what can be learned241
The impact of ageing on monocytes and macrophages118
Ferroptosis mediated DSS-induced ulcerative colitis associated with Nrf2/HO-1 signaling pathway103
Biosurfactants: Potential applications as immunomodulator drugs58
Targeting ROCK signaling in health, malignant and non-malignant diseases57
Immunological aspects of nanocellulose49
Intermittent fasting, a possible priming tool for host defense against SARS-CoV-2 infection: Crosstalk among calorie restriction, autophagy and immune response48
Immune reactivity during COVID-19: Implications for treatment43
Plasticity of monocyte development and monocyte fates40
MiR-149 attenuates endoplasmic reticulum stress-induced inflammation and apoptosis in nonalcoholic fatty liver disease by negatively targeting ATF6 pathway39
JNK signaling in Drosophila immunity and homeostasis38
STAT3 inhibition protects against neuroinflammation and BACE1 upregulation induced by systemic inflammation37
Psychedelics as a novel approach to treating autoimmune conditions37
Macrophage-derived exosomes in cancers: Biogenesis, functions and therapeutic applications36
How nicotine can inhibit cytokine storm in the lungs and prevent or lessen the severity of COVID-19 infection?35
CXC chemokine receptor 3 antagonist AMG487 shows potent anti-arthritic effects on collagen-induced arthritis by modifying B cell inflammatory profile35
A review: Progress in the development of fish Vibrio spp. vaccines34
Natural killer cells in multiple sclerosis: A review32
A comprehensive review on miR-146a molecular mechanisms in a wide spectrum of immune and non-immune inflammatory diseases31
Beyond bacterial killing: NADPH oxidase 2 is an immunomodulator30
Mesenchymal stem cell-derived exosomes suppress proliferation of T cells by inducing cell cycle arrest through p27kip1/Cdk2 signaling29
How NETosis could drive “Post-COVID-19 syndrome” among survivors27
Mechanisms underpinning poor antibody responses to vaccines in ageing27
Targeting the PI3K/Akt/mTOR pathway: A therapeutic strategy in COVID-19 patients26
Low levels of pro-resolving lipid mediators lipoxin-A4, resolvin-D1 and resolvin-E1 in patients with rheumatoid arthritis26
Homeostasis and the functional roles of CD4+ Treg cells in aging26
0.020969867706299